Global Injectable Drug Delivery Devices Market Report 2026–2035: Key Forecasts and Growth Areas
Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Injectable Drug Delivery Devices Market show for the 2026–2030 period?
The market size for injectable drug delivery devices has shown strong expansion in recent years. It is projected to increase from $54.3 billion in 2025 to $58.69 billion in 2026, advancing at a compound annual growth rate (CAGR) of 8.1%. The significant growth observed historically can be attributed to several factors, including the increasing prevalence of chronic diseases, the expansion of biologics and biosimilars, a rise in hospital-based injectable treatments, enhancements in sterile manufacturing practices, and the broader availability of injection devices.
The injectable drug delivery devices market size is anticipated to undergo significant expansion in the coming years. It is projected to reach $79.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This forecasted growth can be attributed to factors such as a growing preference for self-administration devices, an escalating demand for personalized drug delivery, the expansion of biologic drug pipelines, increasing investments in smart injection technologies, and the wider adoption of home healthcare solutions. Prominent trends expected during this period include the increased uptake of prefilled and safety syringes, a rising demand for autoinjectors and pen injectors, the greater use of home-based injectable therapies, the proliferation of wearable and implantable infusion pumps, and an amplified focus on dose accuracy and patient safety.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp
What Drivers Are Shaping The Development Of The Injectable Drug Delivery Devices Market?
The increasing occurrence of chronic diseases is anticipated to drive the expansion of the injectable drug delivery devices market. A chronic disease is defined as an ailment persisting for three months or longer, with the potential to worsen over time. Injectable drug delivery devices provide a dependable and easy way to administer medications for prolonged durations. Such devices are capable of improving patients’ compliance with their prescribed treatments, which helps in the efficient management of chronic conditions and ultimately results in improved health outcomes. For example, data released in June 2024 by the National Health Service, a UK government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (characterized by elevated blood sugar levels, insufficient to be classified as diabetes) in 2023. This figure represents an 18% rise from the 3,065,825 cases recorded in 2022. Consequently, the growing incidence of chronic diseases is propelling the expansion of the injectable drug delivery devices market into the future.
Which Segments Are Contributing To The Growth Of The Injectable Drug Delivery Devices Market?
The injectable drug delivery devices market covered in this report is segmented –
1) By Type: Syringes, Injectors, Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
Subsegments:
1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes
2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors
3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps
Which Trends Are Shaping Activity Within The Injectable Drug Delivery Devices Market?
Major companies within the injectable drug delivery devices market are dedicated to developing cutting-edge solutions, including wearable and smart injectors, to enhance patient convenience, foster adherence, and facilitate self-administration of complex therapies. These innovative wearable and smart injectors are engineered to deliver precise doses of medications, encompassing biologics and large-volume formulations, while minimizing discomfort, reducing user error, and improving the overall treatment experience. As an illustration, in January 2025, Becton, Dickinson and Company, a US-based medical technology company, introduced a range of next-generation devices such as the BD Accuspray Nasal Spray System, BD Hylok Glass Prefillable Syringe, BD Effivax Glass Prefillable Syringe, BD Libertas Wearable Injector, BD Evolve On-body Injector, BD Physioject Disposable Autoinjector, and BD Vystra Disposable Pen. These solutions are characterized by user-friendly designs for independent administration, offer precise and consistent dosing for biologics and vaccines, maintain compatibility with diverse drug formulations, and feature wearable formats that accommodate large-volume delivery, all while ensuring sterility and safety through disposable components. This product launch signifies the industry’s transition towards advanced, patient-centric injectable drug delivery systems focused on enhancing adherence, comfort, and therapeutic outcomes.
Who Are The Primary Competitors In The Global Injectable Drug Delivery Devices Market?
Major companies operating in the injectable drug delivery devices market are Becton Dickinson and Company, Baxter International, Gerresheimer AG, Catalent Inc., Antares Pharma, Owen Mumford, West Pharmaceutical Services Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co. Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Injectable Drug Delivery Devices Market In The Coming Years?
North America was the largest region in the injectable drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Injectable Drug Delivery Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2835&type=smp
Browse Through More Reports Similar to the Global Injectable Drug Delivery Devices Market 2026, By The Business Research Company
Glucose Biosensors Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/glucose-biosensors-global-market-report
Disposable Medical Sensors Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/disposable-medical-sensors-global-market-report
Disposable Medical Devices Sensors Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
